Medical News

RSS

Quality issues persist at hospitals, plastic surgery centers; use of CT scans in ER increases

Despite intensive efforts to improve patient safety, a six-year study at 10 North Carolina hospitals showed no decline in so-called patient harms, which included medical errors and unavoidable mistakes.

1 Dec 2010

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

PhaseBio Pharmaceuticals, Inc., a privately held, clinical-stage biotechnology company developing drugs to treat diabetes, metabolic disease and cardiovascular disease, announced today that it has begun Phase 1/2a clinical testing with its lead compound, Glymera(PB1023), in patients with Type 2 diabetes.

1 Dec 2010

Pfizer awards $2.1 million grant to NCCN to evaluate axitinib in solid tumors

The National Comprehensive Cancer Network has been awarded a $2.1 million grant from Pfizer to develop a program to scientifically evaluate and define the clinical activity of axitinib in various tumor types.

1 Dec 2010

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders announced that it has been granted Orphan Drug Designation by the U.S. Food and Drug Administration for its naloxone lotion for the topical treatment of pruritus accompanying cutaneous t-cell lymphoma (CTCL, also known as mycosis fungoides).

1 Dec 2010

Deficit plans target politically-protected Medicare program

The politically-sacrosanct Medicare program is in the crosshairs of proposals to cut the deficit, prompting possible battles between seniors' advocates and debt-conscious lawmakers, Kaiser Health News reports.

30 Nov 2010

Medical records and medical device interests gain attention from big names, congressional delegation

The Hill: "The new lobby shop of former Rep. Billy Tauzin (R-La.) and his son Tom has registered its first client. The San Francisco-based tech company Resilient Networks Systems has hired Tauzin Consultants to help lobby on the deployment of electronic medical records under the healthcare reform law among other issues, according to lobbying disclosure records.

30 Nov 2010

ACT files IND application to initiate Phase I/II study for Dry AMD

Advanced Cell Technology, Inc. announced today that it has filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using human embryonic stem cell (hESC) derived retinal pigment epithelial (RPE) cells to treat patients with Dry Age-Related Macular Degeneration (Dry AMD).

30 Nov 2010

Researchers reveal ultra-fast processes of DNA photostability

The genetic material of DNA contains shielding mechanisms to protect itself from the exposure to the UV light emitted by the sun. This is of crucial importance, since without photostability i.e. without programmed defense mechanisms against UV irradiation a rapid degradation of DNA and RNA would be the consequence. As part of a project funded by the Austrian Science Fund (FWF) a group of researchers led by Hans Lischka, Quantum Chemist of the University of Vienna, Austria, could, for the first time, comprehensively unravel these ultra-fast processes of the photostability of the nucleobases.

30 Nov 2010

Cordis to distribute OSTIAL PRO Stent Positioning System worldwide

Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The OSTIAL PRO™ is the world's first and only aorto-ostial stent positioning system for coronary and peripheral applications. The OSTIAL PRO™ is intended to optimize the treatment of patients who require a stent implantation for treatment for aorto-ostial blockages.

30 Nov 2010

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Aphios® Corporation today announced that it was awarded Phase I of a Fast Track SBIR grant from the National Institute of Aging (NIA), National Institutes of Health (NIH) for Developing a Novel Alzheimer's Disease Nanodrug.

30 Nov 2010

Lame duck update: Congress delays Medicare payment cuts, fails to roll back health law's 1099 provision

Congress on Monday agreed to delay for one month a cut in Medicare reimbursement rates for doctors, giving a short-term reprieve to a looming crisis over treatment of the nation's elderly.

30 Nov 2010

Anacor completes initial public offering of common stock

Anacor Pharmaceuticals, Inc. today announced the completion of its initial public offering of 12,000,000 shares of its common stock at a price of $5.00 per share.

30 Nov 2010

Health care models: Accountable Care Organizations, medical homes

Kansas Health Institute News Service examines accountable care organizations (ACOs): "In an effort to combat the lack of coordination that is widely recognized as a major shortcoming of the current health system, the new federal health reform law includes provisions intended to encourage wider use of Accountable Care Organizations or ACOs."

30 Nov 2010

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

A new finding out in the December 1st issue of Genes & Development offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn's Disease and sarcoidosis.

30 Nov 2010

Medicaid cuts hurt Miss. Residents, Calif. appeals federal order to reduce prison population amid health concerns

Parents across Mississippi say they are frustrated with state Medicaid officials as programs are downsized and benefits canceled.

30 Nov 2010

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease.

30 Nov 2010

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of golimumab 50 mg plus methotrexate resulted in statistically significant improvements in markers of inflammation and structural damage in patients with active rheumatoid arthritis (RA) compared with placebo plus methotrexate.

30 Nov 2010

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Ikaria, Inc. announced that it has enrolled the first patients in its pivotal Phase III trial for LUCASSIN® (terlipressin). The multi-center, randomized, placebo-controlled, double-blind trial is known as the REVERSE Trial.

30 Nov 2010

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

30 Nov 2010

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Emerging Healthcare Solutions, Inc. announced today that its affiliate, Celulas Genetica, purchased a license to develop and market a revolutionary new medical treatment known as the Rutherford Procedure.

30 Nov 2010

Medical News

Quality issues persist at hospitals, plastic surgery centers; use of CT scans in ER increases

PhaseBio initiates Glymera Phase 1/2a clinical trial in patients with Type 2 diabetes

Pfizer awards $2.1 million grant to NCCN to evaluate axitinib in solid tumors

Elorac's naloxone lotion receives FDA Orphan Drug Designation for pruritus associated with mycosis fungoides

Deficit plans target politically-protected Medicare program

Medical records and medical device interests gain attention from big names, congressional delegation

ACT files IND application to initiate Phase I/II study for Dry AMD

Researchers reveal ultra-fast processes of DNA photostability

Cordis to distribute OSTIAL PRO Stent Positioning System worldwide

NIA awards Aphios Phase I Fast Track SBIR grant for development of novel AD nanodrug

Lame duck update: Congress delays Medicare payment cuts, fails to roll back health law's 1099 provision

Anacor completes initial public offering of common stock

Health care models: Accountable Care Organizations, medical homes

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Medicaid cuts hurt Miss. Residents, Calif. appeals federal order to reduce prison population amid health concerns

NSAID Celebrex may help prevent non-melanoma skin cancer development: Research

Golimumab with methotrexate improves markers of inflammation and structural damage in RA patients

Ikaria initiates enrollment in LUCASSIN Phase III trial for HRS Type 1

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

Celulas Genetica licenses new organ regeneration treatment from Chinese BBFITCL

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News